Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2014
09/25/2014WO2014152382A1 Transdermal delivery of sildenafil and other phosphodiesterase type 5 inhibitors
09/25/2014WO2014152338A1 Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
09/25/2014WO2014152296A1 Abuse deterrent solid dosage form for immediate release with functional score
09/25/2014WO2014152280A1 Transdermal formulations of fluticasone
09/25/2014WO2014152269A1 Pharmaceutical soft gelatin capsule dosage form with modified guar gum
09/25/2014WO2014152226A1 Pharmaceutical soft gelatin capsule dosage form
09/25/2014WO2014152199A1 Antibody drug conjugate (adc) purification
09/25/2014WO2014152196A1 Pharmaceutical composition of s-ketamine hydrochloride
09/25/2014WO2014151853A1 Methods of treating bladder cancer
09/25/2014WO2014151769A1 Compositions including encapsulated isotretinoin and methods for use thereof
09/25/2014WO2014151752A1 Composition and methods for the treatment of peripheral nerve injury
09/25/2014WO2014151725A1 Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process
09/25/2014WO2014151464A1 Film-forming agents formed from silicone pressure sensitive adhesives and silicone acrylic polymers
09/25/2014WO2014151459A1 Aqueous delivery system for low surface energy structures
09/25/2014WO2014151396A1 Aqueous delivery system for low surface energy structures
09/25/2014WO2014151381A1 Bioerodible silicon-based compositions for delivery of therapeutic agents
09/25/2014WO2014151347A1 Minocycline derivatives
09/25/2014WO2014151030A1 Cell proliferation inhibitors and conjugates thereof
09/25/2014WO2014150937A1 Antibody drug conjugates
09/25/2014WO2014150651A1 Racecadotril liquid compositions
09/25/2014WO2014150343A1 Soft gel encapsulation
09/25/2014WO2014150074A1 Compositions and methods for nucleic acid delivery
09/25/2014WO2014149939A1 Dye free liquid therapeutic solution
09/25/2014WO2014149526A1 Phenylephrine resinate particles
09/25/2014WO2014149525A1 Phenylephrine resinate particles and use thereof in pharmaceutical formulations
09/25/2014WO2014149160A1 Polyalkoxylated alcohols as excipients for pharmaceutical compositions
09/25/2014WO2014148997A1 Hollow calcium phosphate particles
09/25/2014WO2014148883A1 Herbaceutical formulations
09/25/2014WO2014148765A1 Dental nanofiber chip equipped with medication and method for manufacturing same
09/25/2014WO2014148582A1 Solventless polyurethane-based adhesive
09/25/2014WO2014148520A1 Solid preparation
09/25/2014WO2014148450A1 Two-layer separation-type eye drop containing squalane
09/25/2014WO2014148378A1 Surfactant-like compound
09/25/2014WO2014148244A1 Oral composition
09/25/2014WO2014147622A1 Compositions comprising collagen and prp for tissue regeneration
09/25/2014WO2014147597A1 Aminofucoidan as a vector for fibrinolysis in thrombotic diseases
09/25/2014WO2014147131A1 Allergen preparation
09/25/2014WO2014147092A1 Implantable preparations for regeneration of tissues and treatment of wounds, their method of preparation, and method of treatment of patients with said implantable preparations
09/25/2014WO2014146677A1 Peg hydrogels functionalized with glucagon and rgds-tetrapeptide and containing stem cells for islet coating
09/25/2014US20140289882 Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage
09/25/2014US20140288295 Oligomer conjugates of heteropentacyclic nucleosides
09/25/2014US20140288280 Cysteine engineered antibodies and conjugates
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140288193 Method for the simultaneous production of ethanol and a fermented, solid product
09/25/2014US20140288192 Dynamic bio-nanoparticle platforms
09/25/2014US20140288190 Hydrogels with biodegradable crosslinking
09/25/2014US20140288189 Water-Stable Hydrogel and Method Using Same
09/25/2014US20140288179 Stable solutions of treprostinil
09/25/2014US20140288146 Novel trialkyl cationic lipids and methods of use thereof
09/25/2014US20140288143 Bladder cancer treatment and methods
09/25/2014US20140288113 Extended Release Compositions Comprising Hydrocodone And Acetaminophen For Rapid Onset And Prolonged Analgesia That May Be Administered Without Regard To Food
09/25/2014US20140288038 Device for transdermal administration of drugs including acrylic polymers
09/25/2014US20140288024 Cyclodextrin-based polymers for therapeutics delivery
09/25/2014US20140288023 Cyclodextrin-based polymers for therapeutics delivery
09/25/2014US20140288000 Dual reactivity potent kunitz inhibitor of fibrinolysis
09/25/2014US20140287995 Stable pharmaceutical formulations of growth factor peptides
09/25/2014US20140287988 Macrogol 15 hydroxystearate formulations
09/25/2014US20140287987 Methods and compositions for the treatment of cancer or other diseases
09/25/2014US20140287984 Polyethylene glycol based prodrug of adrenomedullin and use thereof
09/25/2014US20140287479 Modified lecithin-cholesterol acyltransferase enzymes
09/25/2014US20140287476 Vibrio cholerae 0139 conjugate vaccines
09/25/2014US20140287464 In Vivo Unnatural Amino Acid Expression in the Methylotrophic Yeast Pichia Pastoris
09/25/2014US20140287050 Amino acid conjugates of quetiapine, process for making and using the same
09/25/2014US20140287049 Nanoparticle-based drug delivery
09/25/2014US20140287048 Paste comprising non-steroidal anti-inflammatory drug
09/25/2014US20140287047 Nanoemulsion therapeutic compositions and methods of using the same
09/25/2014US20140287043 Compositions and methods for stabilization of active agents
09/25/2014US20140287034 Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
09/25/2014US20140287028 Use of Chemotherapeutic Agents
09/25/2014US20140287025 Sustained Release Composition For Local Injection to Treat Eye Diseases
09/25/2014US20140287024 Nanoparticle-based delivery system with oxidized phospholipids as targeting ligands for the prevention, diagnosis and treatment of atherosclerosis
09/25/2014US20140287006 Degradation-Stabilised, Biocompatible Collagen Matrices
09/25/2014US20140287001 Compositions Useful For The Treatment Of Gastrointestinal Disorders
09/25/2014US20140286988 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
09/25/2014US20140286970 Pyrrolobenzodiazepines and targeted conjugates
09/25/2014US20140286969 Anti-egfr antibody drug conjugate formulations
09/25/2014US20140286968 Antibody drug conjugate (adc) purification
09/25/2014US20140286963 Methods and compositions for neural disease immunotherapy
09/25/2014US20140286891 Ion binding polymers and uses thereof
09/25/2014US20140286884 Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
09/25/2014US20140286883 Delivery system having stabilized ascorbic acid and other actives
09/25/2014US20140286878 Composition for inhalation
09/25/2014US20140286877 Compositions comprising salbutamol sulphate
09/25/2014US20140286873 Polymer-agent conjugates, particles, compositions, and related methods of use
09/25/2014US20140286865 Synthetic diblock copolypeptide hydrogels for use in the central nervous system
09/25/2014US20140286862 Therapeutic Agents and Uses Thereof
09/25/2014US20140286860 Immunoconjugates with an Intracellularly-Cleavable Linkage
09/25/2014US20140286858 Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
09/24/2014EP2781524A1 Compositions and methods for inhibiting viral adhesion
09/24/2014EP2781507A1 Cationic lipid having improved intracellular kinetics
09/24/2014EP2781225A1 Intestinal fibrosis treatment agent
09/24/2014EP2781224A1 Implantable preparations comrpsing globin insoluble at physiological pH and serum for regeneration of tissues and treatment of wounds.
09/24/2014EP2780459A1 Collagen-like silk genes
09/24/2014EP2780364A2 Proteins with improved half-life and other properties
09/24/2014EP2780350A2 Synthetic derivatives of mpl and uses thereof
09/24/2014EP2780040A1 Methods of treating epidermal growth factor deletion mutant viii related disorders
09/24/2014EP2780039A2 Cytotoxic peptides and antibody drug conjugates thereof
09/24/2014EP2780036A1 Nanoparticle compositions for generation of regulatory t cells and treatment of autoimmune diseases and other chronic inflammatory conditions
09/24/2014EP2780004A1 Film-forming formulation
09/24/2014EP2779997A1 Liquid-filled hard gel capsule pharmaceutical formulations
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 1712